Position in ZYBT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$41,276
-$26,902 QoQ
Shares Held
44,146
-25.5% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 7 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $27,573,815 across 45 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #38 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
379,350 | $3,797,293 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
28,525 | $2,193,572 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
91,114 | $2,059,176 | |
| 4 | VTRS |
Viatris Inc
|
144,138 | $1,947,304 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
87,736 | $1,718,748 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
26,428 | $1,566,387 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,626 | $1,324,607 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,324 | $1,320,920 |
All Filings in ZYBT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,276 | 44,146 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $68,178 | 59,286 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $90,623 | 34,589 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||